Pharmaceutical and Life Sciences companies are in the public spotlight as they pursue advanced therapies and vaccines to combat the coronavirus pandemic. Productivity, flexibility and…

On May 26, 2020, the EU Medical Device Regulation (MDR) exited its transition period. There are still questions about how it operates – and the…

You can’t deliver tomorrow’s innovation if you’re still using yesterday’s business models. For Healthcare 4.0, that means designing services and solutions around patients and empowering…

With the patient taking center stage, digitization is gaining pace within Life Sciences. This blog looks at how digital technology is going to shape every stage of the drug lifecycle for life science and pharma companies in 2020.

OpenText™ Life Science Express has a new name: OpenText™ Life Sciences Smart View. Learn about it here. If you work in the Life Sciences industry,…

The market is growing fast for Healthcare Artificial Intelligence (AI), estimated to reach over $8 billion by 2026. During this year’s Intelligent Health conference, there…

So far, 2019 has been the worst year ever for data breaches in the healthcare and Life Science sector. And attacks aren’t just increasing –…

Every pharmaceutical company wants to accelerate the drug development process – from discovery to commercial success – to deliver new treatments that improve patient outcomes….

A lot has happened in the Life Sciences industry since the last update to OpenText™ Documentum for Life Sciences in 2018. Regulatory changes, such as…

I recently joined OpenText™ as the global industry strategist for life sciences and for my first blog post, I want to share insight into some…

Artificial intelligence or AI is fast becoming a key technology for the life sciences field. Combined with advanced analytics, it has almost limitless potential to…

When major acquisitions happen, market analysts, competitors, customers, and employees alike are watching closely to determine what’s next. In fact, employees like me were not…